One of Only Ten Companies on Forbes Top 100 List for Three YearsCHELMSFORD, Mass.–(Business Wire)–ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of resuscitationdevices and related software solutions, has been named one of America`s 100 MostTrustworthy Companies by Forbes for the third consecutive year. Of the approximately 12,000 public companies reviewed to compile the list, ZOLLwas one of the six medical companies listed on the Top 100. ZOLL also receivedspecial recognition as one of only 10 companies that has made the list for allthree years it has been published. This is the third year that Audit Integrity has provided Forbes with a listof 100 American companies that, by its assessment, have the highest Accountingand Governance Risk (AGR) ratings, which evidence clear financial reporting andtransparent corporate governance. According to Audit Integrity, risk scores arederived from statistical analysis, which incorporates over 100 metrics thattogether provide a comprehensive view of management behavior and motivation. In the independent firm`s judgment, the top 100 companies have a low incidenceof risk factors in accounting, governance and high risk events, and “stand instark contrast with the companies fraught with scandal, fraud and corporateexcesses in today`s headlines.” The full report may be viewed at ordownloaded at “We are honored that Forbes has recognized ZOLL for having the highest standardsof corporate integrity for the third consecutive year,” said Richard A Packer,Chairman and Chief Executive Officer of ZOLL. “This award is a great credit toZOLL`s shareholders, employees and customers, who support and share our strongcommitment to providing clinical advances in resuscitation.” ZOLL`s innovative resuscitation products for treating sudden cardiac arrest, theworld`s number one cause of unexpected death, have been instrumental inimproving the quality of CPR and survival rates.

Examples include:* AutoPulse®, an innovative non-invasive cardiac support pump that automateschest compressions; * LifeVest®, the world`s first and only wearable external defibrillator; * Defibrillators featuring Real CPR Help®, auditory and visual real-timefeedback on the rate and depth of chest compressions to encourage high-qualityCPR to maximize blood flow; * See-Thru CPR®, a unique technology that helps to minimize interruptions duringCPR-one of the key recommendations of the American Heart Association`sGuidelines for Advanced Life Support; * Resuscitation products from data management to power infusion andhypothermia.About ZOLL Medical CorporationZOLL Medical Corporation is committed to developing technologies that helpadvance the practice of resuscitation. With products for pacing, defibrillation,circulation, hypothermia, and fluid resuscitation, ZOLL provides a comprehensiveset of technologies, including Real CPR Help® and See-Thru CPR®, that helpclinicians, EMS professionals, and lay rescuers resuscitate sudden cardiacarrest or trauma victims. ZOLL also designs and markets software that automatesthe documentation and management of both clinical and non-clinical information. ZOLL markets and sells its products in more than 140 countries. The Company hasdirect operations, distributor networks, and business partners throughout theU.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, andAustralia. During 2008 ZOLL marked the 25th anniversary of the company`sresuscitation product development. ZOLL, AutoPulse, LifeVest, Real CPR Help, andSee-Thru CPR are registered trademarks of ZOLL Medical Corporation INVESTOR CONTACT:ZOLL Medical CorporationA.

Ernest Whiton, 978-421-9655Chief Financial OfficerorMEDIA CONTACT:ZOLL Medical CorporationDiane Egan, Copyright Business Wire 2009. * Sets debt limit of 60 percent of regulated asset base Italy * Fitch downgrade does not affect debt cost(Adds further details on debt, shares) ROME, April 22 (Reuters) – Italian power grid operator TernaSpA (TRN.MI) has enough resources to cover dividends andinvestments through 2013, Chief Executive Flavio Cattaneo said “The company is solid and competitive. Between credit linesand financing we have the resources to cover all of theinvestments and dividends from now until 2013,” Cattaneo told ashareholders meeting. Terna has set a debt limit of 60 percent of its regulatedasset base (RAB), he said. At the end of 2008 Terna had net debt of 3.366 billion euros($4.35 billion).

The Fitch ratings downgrade earlier this month has notaffected Terna’s cost of debt, Cattaneo said. Terna’s shares were down 0.22 percent at 2.31 euros at 1111GMT when the DJ Stoxx European utilities sector index .SX6Pwas down 0.89 percent. (Reporting by Stefano Bernabei; Editing by Greg Mahlich) Italy. NEW YORK (Reuters) – Health insurer WellPoint Inc (WLP.N) posted slightly lower first-quarter profit on Wednesday, hurt by large investment losses, but results far surpassed Wall Street forecasts.WellPoint lifted the lower end of its 2009 profit forecast, but maintained the high end.Net income at the largest U.S. health insurer by membership fell to $580.4 million from $588.1 million.

Earnings per share rose to $1.16 from $1.07 a year earlier when the company had more shares outstanding.Results in the 2009 quarter included net realized investment losses of $228.4 million, or 46 cents per share. Excluding those losses, earnings were 37 cents ahead of the average estimate of analysts, according to Reuters Estimates.Revenue fell 0.4 percent to $15.3 billion.WellPoint’s benefit expense ratio, which measures the percent of premiums spent on medical costs, improved substantially to 81.6 percent from 85.1 percent a year ago. Analysts at UBS had expected 83.8 percent.The Indianapolis-based company cited disciplined pricing and operational improvements in its Medicare plans for seniors and health plans for local businesses.WellPoint expects 2009 earnings of $5.14 to $5.20 per share including the investment losses — which equates to $5.60 to $5.66 excluding them. In February, WellPoint forecast $5.51 to $5.66 per share for 2009 excluding any potential investment losses.On Tuesday, rival UnitedHealth Group Inc (UNH.N) posted sharply higher-than-expected earnings, but shares fell after it refrained from raising its full-year profit forecast.WellPoint shares are down about 1 percent in 2009, compared with a 9 percent drop for the S&P Managed Health Care index .GSPHMO, amid wide concerns over the financial impact of U.S. health reform measures.(Reporting by Lewis Krauskopf; Editing by Derek Caney). 6 runs in 3 games = 1 win. The lineup the Indians have been trotting out has been just plain terrible.